Long-Term Efficacy and Safety of Efavirenz Dose Reduction to 200 mg Once Daily in a Caucasian Patient with HIV

Author: >   Gómez Alicia Iglesias  

Publisher: Adis International

ISSN: 1173-2563

Source: Clinical Drug Investigation, Vol.30, Iss.6, 2010-06, pp. : 405-411

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract